在体内CRISPR查可识别骨髓瘤中CART细胞功能的修饰剂
Nelson H Knudsen1,2,3, Giulia Escobar1,2,3,4, Felix Korell1,2,3,4
1Krantz Family Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Nature
|September 24, 2025
概括
鉴定改善多发性骨髓瘤T细胞治疗的基因至关重要. 切除CDKN1B可以提高CAR T细胞的功能和存活率,为更好的癌症治疗结果提供了有前途的策略.
科学领域:
- 免疫学
- 癌症学
- 基因编辑
背景情况:
- 化学抗原受体 (CAR) T 细胞在血液癌症中表现出高疗效.
- 许多患者的CAR T细胞损失导致复发.
- 了解限制CAR T细胞持久性的因素对于改善治疗至关重要.
研究的目的:
- 通过体内CRISPR查,识别影响CAR T细胞持久性和功能的基因.
- 研究CAR T细胞从制造到瘤存活的表现.
- 发现用于增强多发性骨髓瘤T细胞疗效的新目标.
主要方法:
- 针对B细胞成熟抗原的CAR T细胞进行了体内功能丧失CRISPR查.
- 在体外和体内追踪编辑的T细胞的扩张和持久性.
- 分析了早期和晚期CAR T细胞适应性的基因影响.
主要成果:
- 确定了CAR T细胞扩张和持久性的特定环境调节剂.
- 在体外增强RASA2和SOCS1T细胞扩张.
- 在体内早期,PTPN2,ZC3H12A和RC3H1的丧失带来了生长优势.
- CDKN1B被确定为限制晚期CAR T细胞适应性的关键因素.
- 切除CDKN1B显著改善了CAR T细胞的增殖,效应器功能,瘤清除和存活率.
结论:
- 基因干扰对CAR T细胞的影响随时间和环境而变化.
- CDKN1B是产生多发性骨髓瘤强大的CAR T细胞的有希望的目标.
- 在体内查是一个有价值的方法来识别基因以加强CAR T细胞治疗.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


